Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FENOFIBRATE
- Fenofibrate in Patients With Cervical Intraepithelial Neoplasia and Invasive Cervical Carcinoma
- Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis
- Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
- Prolonged Remission Induced by Phenofibrate in Children Newly Diagnosed With Type 1 Diabetes.
- Fenofibrate Role in Breast Cancer Patients
- Repurposing Fenofibrate in Modulating mTOR/NLRP3 Inflammasome in Patients With Ulcerative Colitis
- Fenofibrate in Ulcerative Colitis
- Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis
- Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
- Genetic-Dependent Cardiovascular Response to PPAR-Alpha Agonist Fenofibrate
- A Study to Assess the Role of Fenofibrate in Preventing Ischemic Cholangiopathy After Liver Transplantation
- Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males With Klinefelter Syndrome
- Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
- Oxford - Fibrates in Aortic Stenosis
- A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes
- Serine and Fenofibrate Study in Patients With MacTel Type 2
- Effects of Oral Fenofibrate on Retinal Thickness and Macular Volume
- Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.
- Role of Fenofibrate in Indirect Neonatal Hyperbilirubinemia: a Randomized Control Trial
- Fenofibrate for Patients With COVID-19 Requiring Hospitalization
- Fenofibrate for Prevention of DR Worsening
- Fenofibrate Versus Curcumin in Type 2 Diabetic Patients
- Fenofibrate Therapy in Pathological Unconjugated Hyperbilirubinemia in Full Term Infants
- Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy
- Effects of Fenofibrate Therapy in Diabetic Nephropathy
- Fenofibrate in Type 2 Diabetes
- Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
- A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia
- Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females
- Evaluation of Fenofibrate on Radiation-induced Skin Injury
- Safety and Efficacy of Fenofibrate as a Treatment for Huntington's Disease
- An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
- An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia
- Lowering Events in Non-proliferative Retinopathy in Scotland
- A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337
- PROMINENT-Eye Ancillary Study (Protocol AD)
- Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment
- Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function
- Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia
- Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA
- Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic Function
- An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
- Randomized Comparative Efficacy and Safety Study of Intermittent Simvastatin and Fenofibrate in Hemodialysis
- Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid
- Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
- Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)
- Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)
- Fenofibrate Treatment in SCI
- Fenofibrate and Propranolol in Burn Patients
- A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.
- Evaluate the Efficacy of Fenofibrate on Microalbuminuria
- Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fed Conditions
- Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fasting Conditions
- Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed Dyslipidemia
- The Pharmacokinetic Study of the Fixed-dose Combination of Micronized Fenofibrate and Pitavastatin Ca
- Effects of Combined Therapy With Statin Plus Fenofibrate on Coronary Atherosclerotic Plaque Compared With Statin Alone
- Clinical Trial to Evaluate the Efficacy and Safety of Pravafenix Cap to Verify the Superiority Than Atorvastatin
- Medication Development in Alcoholism: Investigating PPAR Agonists
- Characterization of High Density Lipoprotein (HDL) in Type 2 Diabetes (T2D) After Fenofibrate or Niacin Treatment
- CKD-337 Drug Interaction Study
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome
- Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma
- Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin
- The Effects of Coenzyme A Combined With Statin on Serum Lipids in Patients With Hyperlipidemia
- Effects of Fenofibrate on Endothelial Progenitor Cells in Diabetes
- Comparison of Coenzyme A and Fenofibrate for Safety and Efficacy On Patients With Hyperlipidemia
- Initial Screening of Gemfibrozil as a Novel Treatment for Tobacco Addiction
- Evaluation of Pharmacokinetic Interaction Between Micronized Fenofibrate and Pitavastatin
- Lipid Biomarkers for Diabetic Heart Disease
- Effect of Alirocumab (SAR236553/REGN727) Administered on Top of Ezetimibe or Fenofibrate on Lipid Profiles in Healthy Subjects
- A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats
- Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate
- A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia
- Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients
- A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia
- A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic
- Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate
- Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia
- Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRT
- Relative Bioavailability Study of Lipidil® Supra (Fenofibrate 160mg) Versus SYO-0805 (Fenofibrate 65mg)
- The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.
- Insulin Resistance in Non-alcoholic Fatty Liver Disease
- Effect of Fenofibrate Conversion on Triglyceride Levels in Patients on Statin Therapy
- Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia
- The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers
- Pilot Study of Fenofibrate for PSC
- Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis
- Comparison of Fenofibrate and Niacin in Patients With Hypertriglyceridemia and Low High-Density Lipoprotein (HDL)-Cholesterol
- Effects of Fenofibrate on Gene Expression in Healthy Volunteers
- The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines
- Effects of Hypolipemic Treatment on Adipokines
- Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia
- Study of Trilipix Effects on Lipids and Arteries
- Predictors of Response to Fenofibrate
- Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia
- Differential Metabolic Effects of Fenofibrate and Fatty Acid
- Pilot Trial of Statin Use in Burn Patients
- A Multicenter Randomized Parallel-group Study to Investigate the Efficacy of a Combination of Rosuvastatin and Fenofibrate in the Patients With Diabetes or Atherosclerotic Vascular Diseases With Metabolic Syndrome
- Bioequivalence Study of Fenofibric Acid Versus Tricor® (Fenofibrate)
- Fed Bioequivalence Study of Fenofibric Acid Versus TriCor® (Fenofibrate)
- Effect of Genes on Rosuvastatin Therapy for Hyperlipidemia
- Fenofibrate Bioequivalence Study (0767-031)
- Treatment of Hyperlipidemia and Sexual Dysfunction
- Metformin in Overweight Type 2 Diabetes Mellitus
- A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™
- Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome
- The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans
- Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients
- Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)
- Effect of Fenofibrate on Sleep Apnea Syndrome
- Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels
- High-density Lipoprotein (HDL) Cholesterol in Women Taking Tibolone
- Bioequivalency Study of Fenofibrate 160mg Tablets Under Fasting Conditions
- Bioequivalence Study of Fenofibrate 160mg Tablets Under Fed Conditions
- Effects of Fenofibrate on Adipocytokine Levels In Hypertriglyceridemic Patients
- Mitochondrial Oxidation and Insulin Resistance in Burn Patients Treated With Fenofibrate
- Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED)
- A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.
- A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes
- Effect of Choline Fenofibrate (SLV348) on Macular Edema
- ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) Study
- Assessment of Mechanisms of Improved Wound Healing
- 12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia
- LXRA Gene Polymorphisms and Response to Fenofibrate
- Pharmacological Regulation of Fat Transport in Metabolic Syndrome
- Effect of a PPAR-Alpha Agonist on the Age Related Changes in Myocardial Metabolism and Mechanical Function
- Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
- Fenofibrate and Pharmacogenetic Impact in Dyslipidemia
- Use of Fenofibrate for Primary Biliary Cirrhosis
- Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS
- Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease
- Effect of Fenofibrate on Kidney Function: a Six-week Randomized Cross-over Trial in Healthy People
- Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study)
- Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia
- Effect of a Fibrate and a Statin on Endothelial Dysfunction
- Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia
- Tissue Lipids and Insulin Resistance
- Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation
- A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia
- Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis
- The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study
- Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome
- Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033
- Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin
- Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study
- Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO
- Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin
- Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration
- Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI
- Substrate Cycling in Energy Metabolism
- Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents
- Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer
- Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin Monotherapy
- A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.
- Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy
- A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic Syndrome
- Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes
- Acceptability of a Fixed Combination of Fenofibrate and Metformin
- Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study
- Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia
- Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy
- Obesity and Nonalcoholic Fatty Liver Disease
- GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate
- Insulin Resistance in Non-alcoholic Fatty Liver Disease
- Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.
- Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week Extension
- Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia
- A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin
- Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.
- Dyslipidemia Study Investigating The Increase In "Good Cholesterol"
- GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol
- Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.
- Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate
- A Study in People With Abnormal Fat Levels in the Blood
- A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)
- Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)
- Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)
- Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224)
- The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART)
- Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids
- Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Clinical trials list
click for details